Date: 2012-09-24
Type of information: Services contract
Compound: yeast two-hybrid (Y2H) screens
Company: Hybrigenics (France) undisclosed American life sciences company (USA)
Therapeutic area:
Type agreement: services
Action mechanism: Yeast Two-Hybrid (Y2H) and related services are used to identify, validate and inhibit protein interactions for researchers in all areas of life sciences.
Disease:
Details: Hybrigenics has announced that Hybrigenics Services, its fully-owned subsidiary specialised in protein interactions, has renewed a 3-year research services agreement worth $ 2.4 million ( (€1.86 million)) with an American life sciences company. Hybrigenics Services will continue to perform yeast two-hybrid (Y2H) screens on demand and to compile exclusive bioinformatics databases of newly identified protein interactions.
The initial 3-year agreement was signed in 2009. Under the renewal terms, the yearly commitment has been increased from $ 700,000 to 790,000 (+13%).
Financial terms: The contract is worth $ 2.4 million (€1.86 million).
Latest news:
